Ferrous Fumarate and Polysacchride Iron Vitamin Mineral Complex Supplement · FERROUS FUMARATE 62.5 mg/1; FERROUS ASPARTO GLYCINATE 62.5 mg/1; FOLIC ACID 1 mg/1; ASCORBIC ACID 210 mg/1; NIACIN 20 mg/1; THIAMINE MONONITRATE 5 mg/1; RIBOFLAVIN 5 mg/1; CALCIUM PANTOTHENATE 5 mg/1; PYRIDOXINE HYDROCHLORIDE 25 mg/1; BIOTIN 300 ug/1 · Capsule · Oral · U.S. Pharmaceutical Corporation
NDC 52747-0712-60 · 90 CAPSULE in 1 BOTTLE, PLASTIC · UNAPPROVED DRUG OTHER · View full market →
Only one company currently supplies this market — there is no backup if it stumbles. The price has held steady around $0.6552 per unit over the past year. Put together: worth watching — several of the pressures that precede supply trouble are present at once.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.
The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.
The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| U.S. Pharmaceutical Corporation | FERROUS FUMARATE 62.5 mg/1; FERROUS ASPARTO GLYCINATE 62.5 mg/1; FOLIC ACID 1 mg/1; ASCORBIC ACID 210 mg/1; NIACIN 20 mg/1; THIAMINE MONONITRATE 5 mg/1; RIBOFLAVIN 5 mg/1; CALCIUM PANTOTHENATE 5 mg/1; PYRIDOXINE HYDROCHLORIDE 25 mg/1; BIOTIN 300 ug/1 | Aug 26, 2026 | Sep 2, 2026 |
| U.S. Pharmaceutical Corporation | FERROUS FUMARATE 210 mg/1; FERROUS ASPARTO GLYCINATE 300 ug/1; FOLIC ACID 5 mg/1; ASCORBIC ACID 62.5 mg/1; NIACIN 62.5 mg/1; THIAMINE MONONITRATE 1 mg/1; RIBOFLAVIN 20 mg/1; CALCIUM PANTOTHENATE 25 mg/1; PYRIDOXINE HYDROCHLORIDE 5 mg/1; BIOTIN 5 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| U.S. Pharmaceutical Corporation | ASCORBIC ACID 210 mg/1; BIOTIN 300 ug/1; CALCIUM PANTOTHENATE 5 mg/1; FERROUS ASPARTO GLYCINATE 62.5 mg/1; FERROUS FUMARATE 62.5 mg/1; FOLIC ACID 1 mg/1; NIACIN 20 mg/1; PYRIDOXINE HYDROCHLORIDE 25 mg/1; RIBOFLAVIN 5 mg/1; THIAMINE MONONITRATE 5 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Integra Plus — NDC 52747-0712-60," retrieved September 3, 2026, https://drugdashboards.com/drug/52747071260.
Free to cite with attribution — see how the data is put together.